FMR LLC

Position in PYXS — Pyxis Oncology, Inc.

CIK 315066 BOSTON, MA

Position in PYXS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$17,391

+$2,605 QoQ

Shares Held

11,912

-7.4% QoQ

Ownership

0.019%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#51

of 78 holders

Holding Since

Mar 2022

13 quarters on record

Voting authority Sole 7.714909335124244.ToString("F0")% Shared 0.ToString("F0")% None 92.28509066487575.ToString("F0")%

Healthcare · as of Mar 31, 2026

FMR LLC holds $49,683,576,696 across 351 Biotechnology names. PYXS ranks #293 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	14,579,166	$4,823,808,652
2	ARGX	Argenx SE	4,991,034	$3,644,702,577
3	MRNA	Moderna, Inc.	45,672,024	$2,320,138,818
4	ROIV	Roivant Sciences Ltd.	77,981,253	$2,160,080,705
5	INSM	INSMED Inc	13,160,167	$2,151,950,504
6	IONS	Ionis Pharmaceuticals Inc	24,556,637	$1,843,957,869
7	RPRX	Royalty Pharma plc	25,152,242	$1,206,553,046
8	REGN	Regeneron Pharmaceuticals, Inc.	1,518,192	$1,173,015,865

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$17,391	11,912	-7.4%	Shares	Defined	2026-05-15
2025-12-31	$14,786	12,858	-16.8%	Shares	Defined	2026-02-17
2025-09-30	$34,309	15,455	-83.7%	Shares	Defined	2025-11-13
2025-06-30	$104,330	94,846	+9.5%	Shares	Defined	2025-08-14
2025-03-31	$84,921	86,655	+2.1%	Shares	Defined	2025-05-12
2024-12-31	$132,425	84,888	+2037.2%	Shares	Defined	2025-02-13
2024-09-30	$14,576	3,972	+397100.0%	Shares	Defined	2024-11-13
2024-03-31	$4	1	-99.7%	Shares	Defined	2024-05-13
2023-09-30	$688	346	+102.3%	Shares	Defined	2023-11-13
2023-06-30	$437	171	-80.0%	Shares	Defined	2023-08-11
2022-09-30	$1,684	855	-0.3%	Shares	Defined	2022-11-10
2022-06-30	$2,042	858	+565.1%	Shares	Defined	2022-08-12
2022-03-31	$521	129	—	Shares	Defined	2022-05-13
No filing history on record for this holder in this stock.